Cumberland Pharmaceuticals (CPIX) Institutional Ownership $2.27 -0.05 (-2.16%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cumberland Pharmaceuticals (NASDAQ:CPIX)CurrentInstitutional OwnershipPercentage15.51%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$81.86K Get CPIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cumberland Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CPIX Institutional Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Cumberland Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024 Dimensional Fund Advisors LP304,109$465K0.0%-15.0%2.143% 10/24/2023 Bank of New York Mellon Corp75,268$142K0.0%N/A0.524% 7/27/2023 B. Riley Wealth Advisors Inc.90,298$133K0.0%N/A0.625% 2/10/2023True Capital Management12,025$27K0.0%N/A0.082% 5/24/2022 M Holdings Securities Inc.10,750$30K0.0%N/A0.073% 2/10/2022 Acadian Asset Management LLC147,294$683K0.0%-9.2%0.995% Get the Latest News and Ratings for CPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/9/2022 Dimensional Fund Advisors LP652,561$3.05M0.0%-6.3%4.406% 11/15/2021 Berkshire Asset Management LLC PA176,185$472K0.0%+3.1%1.184% 11/15/2021 Dimensional Fund Advisors LP696,654$1.88M0.0%-7.8%4.682% 11/12/2021 Renaissance Technologies LLC664,564$1.78M0.0%-5.3%4.466% 11/9/2021BlackRock Inc.333,051$892K0.0%-15.9%2.238% 8/17/2021 Berkshire Asset Management LLC PA170,830$486K0.0%+3.2%1.135% 8/13/2021 Renaissance Technologies LLC701,463$2.00M0.0%-6.9%4.661% 8/13/2021 California Public Employees Retirement System10,205$29K0.0%-79.3%0.068% 8/13/2021 Ariel Investments LLC12,033$34K0.0%-94.3%0.080% 8/12/2021 Dimensional Fund Advisors LP755,500$2.15M0.0%+2.4%5.020% 5/21/2021 Citadel Advisors LLC17,005$52K0.0%N/A0.113% 5/18/2021 Citadel Advisors LLC17,005$52K0.0%N/A0.114% 5/14/2021 Arrowstreet Capital Limited Partnership10,700$32K0.0%N/A0.072% 5/14/2021 Dimensional Fund Advisors LP737,881$2.24M0.0%-5.6%4.945% 5/13/2021 Renaissance Technologies LLC753,053$2.28M0.0%+11.5%5.047% 5/12/2021 M Holdings Securities Inc.10,750$33K0.0%N/A0.072% 5/11/2021 Acadian Asset Management LLC175,015$529K0.0%+66.7%1.173% 3/8/2021 Dimensional Fund Advisors LP781,891$2.30M0.0%-2.1%5.207% 2/25/2021 Dimensional Fund Advisors LP781,891$2.30M0.0%-2.1%5.207% 2/12/2021 Stonepine Capital Management LLC188,703$557K0.4%-68.0%1.257% 2/12/2021 Ariel Investments LLC821,096$2.42M0.0%+4.9%5.468% 2/10/2021 Renaissance Technologies LLC675,159$1.99M0.0%+12.6%4.496% 2/10/2021 Sterling Financial Planning Inc.22,031$65K0.1%N/A0.147% 11/6/2020BlackRock Inc.364,974$1.17M0.0%+2.1%2.411% (Data available from 1/1/2016 forward) CPIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CPIX shares? During the previous two years, the following institutional investors and hedge funds held shares of Cumberland Pharmaceuticals shares: Dimensional Fund Advisors LP ($465K), Bank of New York Mellon Corp ($142K), and B. Riley Wealth Advisors Inc. ($133K), True Capital Management ($27K).Learn more on CPIX's institutional investors. What percentage of Cumberland Pharmaceuticals stock is owned by institutional investors? 15.51% of Cumberland Pharmaceuticals stock is owned by institutional investors. Learn more on CPIX's institutional investor holdings. Which institutional investors have been buying Cumberland Pharmaceuticals stock? The following institutional investors have purchased Cumberland Pharmaceuticals stock in the last 24 months: B. Riley Wealth Advisors Inc. ($90.30K), Bank of New York Mellon Corp ($75.27K), and True Capital Management ($12.03K). How much institutional buying is happening at Cumberland Pharmaceuticals? Institutional investors have bought a total of 177,591 shares in the last 24 months. This purchase volume represents approximately $302.05K in transactions. Which Cumberland Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Cumberland Pharmaceuticals stock in the last 24 months: Dimensional Fund Advisors LP ($53.51K). How much institutional selling is happening at Cumberland Pharmaceuticals? Institutional investors have sold a total of 53,506 shares in the last 24 months. This volume of shares sold represents approximately $81.86K in transactions. Related Companies ASMB Major Shareholders LLY Major Shareholders JNJ Major Shareholders ABBV Major Shareholders MRK Major Shareholders PFE Major Shareholders BMY Major Shareholders ZTS Major Shareholders RPRX Major Shareholders JAZZ Major Shareholders This page (NASDAQ:CPIX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
